
Australian Government Doubles Down on Urgent Care Clinics
The Australian government has bet big on Medicare Urgent Care Clinics (UCCs) and is now winning over some previously skeptical general practitioners (GPs). Still, not everyone is convinced that these clinics will relieve the pressure on emergency departments.
Since 2022, the government has spent hundreds of millions of dollars establishing 87 Medicare UCCs around the country. It is now doubling down on this investment, with 50 more clinics planned.
Medicare UCCs offer free or bulk-billed healthcare services for urgent conditions that are not life-threatening. So far, almost 1.5 million people have visited these centers.
'Medicare UCCs have already delivered significant benefits for Australians through high-quality, accessible, walk-in care,' a spokesperson for the Department of Health, Disability and Ageing told Medscape Medical News .
The Royal Australian College of GPs (RACGP) and the National Council of Primary Care Doctors raised serious concerns about the expansion of the Medicare UCCs before the federal election, arguing that it would be more cost-effective to fund general practices.
RACGP's Stance Softens
Following the Labor Party's landslide victory, however, it's clear that these Medicare UCCs are here to stay. Moreover, they are offering some RACGP members high paying and interesting work.
'GPs working in UCCs report a high level of job satisfaction,' Sneha Wadhwani, MBChB, regional clinical director for New South Wales and head of GP Wellbeing at ForHealth, told Medscape Medical News . ForHealth runs 36 Medicare UCCs and is the largest provider of bulk-billed primary care services in Australia.
Sneha Wadhwani, MBChB
'The 2 PM to 10 PM shifts really suit me because I'm wanting to work in my other role as associate professor [of urgent care] at the University of the Sunshine Coast,' John Adie, MBChB, PhD, clinical director of the South Brisbane Medicare UCC, told Medscape Medical News . Adie's clinic is located within a general practice and is staffed by one primary care physician and one nurse 7 days per week.
Just over half (55%) of presentations at the clinic are for minor infections such as bronchitis or tonsillitis. Around 20% relate to minor injuries, including wounds that can be closed with stitches, glue, or Steri-Strips; fractures; or foreign bodies that can be removed from ears with air suction and from eyes with a slit lamp. 'If you come to us, there's a 97% chance that you will not have to go to the emergency department,' said Adie.
John Adie, MBChB, PhD
As the Medicare UCCs have become more established, the RACGP's stance seems to have softened. 'We value the work that our members are doing in those clinics, and we're keen to support them,' Michael Wright, MBBS, PhD, president of the RACGP, told Medscape Medical News .
Underlying Problems Remain
An interim evaluation published in March showed that Medicare UCCs were performing well, with median waiting times of 14.5 minutes. About 46% of patients avoid an emergency department visit by attending a UCC. But the evaluation also showed room for improvement. 'We're keen to work with the government to address some of the problems that have been identified,' said Wright.
Michael Wright, MBBS, PhD
The Medicare UCCs are substantially cheaper than emergency departments. Each presentation at a UCC costs $246.50 instead of $616 at an emergency department. But this amount is 'more than five times what a GP consult rebate is for a 20-minute consultation,' said Wright.
It is difficult to determine the impact of Medicare UCCs on emergency departments without a more rigorous analysis, Henry Cutler, PhD, professor of health economics and director of the Macquarie University Centre for the Health Economy in Sydney, told Medscape Medical News . 'It needs more of an academic approach to evaluate these programs,' he said.
Henry Cutler, PhD
Medicare UCCs are a 'Band-Aid solution' that does not address the underlying problems that are putting pressure on emergency departments, Charlotte Hespe, MBBS, PhD, the head of General Practice at The University of Notre Dame in Sydney, told Medscape Medical News . The main problem is patients' decision not to see their GP for preventive care and chronic disease management because it is too expensive, she added.
Charlotte Hespe, MBBS, PhD
Bulk-billing rates are declining because government funding has not kept pace with the costs of running a general practice. Relief seems to be on the way, however, with $7.9 billion being allocated toward supporting general practices to bulk bill starting November 1.
Medicare UCCs are offering 'massive hourly rates,' making it 'hard for us to compete for that workforce,' Toby Gardner, MBBS, director of a private UCC in Launceston, told Medscape Medical News . Gardner's clinic lost state government funding after the Medicare UCCs were established. 'It's made it harder for us to remain financially viable,' he said.
Toby Gardner, MBBS
Despite these setbacks, the private clinic has used its relationships with local pathology and x-ray providers to keep patients out of public hospital emergency departments, which previously had some of the worst waiting times in the country.
Another concern about Medicare UCCs is fragmentation of care. 'Only 68% of patient presentations to Medicare UCCs resulted in an electronic discharge summary being sent to the GP,' said Wright. 'Better transitions of care are the key to preventing hospital admissions and readmissions and saving costs.'
Wadhwani, Adie, Wright, Cutler, Hespe, and Gardner reported having no relevant financial relationships.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
34 minutes ago
- Medscape
Nefecon Shows IgAN Benefits Regardless of Baseline eGFR
Nefecon, an oral targeted-release formulation of budesonide that targets drug release into the distal ileum, provided significant improvements in the loss of kidney function in patients with immunoglobulin A nephropathy (IgAN) at 9 months, regardless of baseline estimated glomerular filtration rate (eGFR) status, according to a new subanalysis of the phase 3 NeflgArd study. METHODOLOGY: Patients in the NeflgArd study with primary IgAN were randomly assigned to one of two groups of 182 patients each to receive either treatment with 16 mg Nefecon or placebo daily, along with supportive care with renin-angiotensin system inhibition. This was followed by a 15-month off-drug observational period allowing for continued supportive care. For the subanalysis, the patients were further stratified on the basis of eGFR deciles in relation to the overall study population, with levels above and below 38, 43, 47, 51, 55, 60, 66, 72, and 82 mL/min/1.73 m 2 . . The median eGFR overall was 55.49 mL/min/1.73 m2 and was balanced across the Nefecon and placebo groups. TAKEAWAY: The relative benefit of Nefecon in terms of eGFR was seen across most deciles and timepoints and showed a generally greater benefit in higher baseline eGFR groups (above 72 mL/min/1.73 m 2 ). ). Furthermore, the relative urine protein-creatinine ratio benefit was observed from month 9 with Nefecon vs placebo regardless of baseline eGFR, with a continued reduction to month 12, followed by a maintained treatment benefit to month 24. The eGFR benefits with Nefecon over placebo were observed among patients within the upper and lower deciles over 2 years. eGFR showed a pronounced on-treatment benefit and a delay in decline during the observation period. IN PRACTICE: 'This NefIgArd subanalysis demonstrated that the efficacy of a 9-month Nefecon treatment course in reduction of proteinuria and preservation of kidney function was independent of baseline eGFR,' said first author Jonathan Barratt, MD, of the College of Life Sciences, University of Leicester, UK. 'So, we should be confident about treating people with Nefecon across the full range of eGFR in terms of the eGFR saving we're going to see, but also the proteinuria reduction,' he added. SOURCE: The findings were reported this week at the 62nd European Renal Association (ERA) Congress 2025. DISCLOSURES: The study was funded by Calliditas Therapeutics AB. Credit Lead image: Medscape Medscape Medical News © 2025 WebMD, LLC Cite this: Nefecon Shows IgAN Benefits Regardless of Baseline eGFR - Medscape - June 06, 2025.


Health Line
44 minutes ago
- Health Line
CHAMPVA and Medicare: Which Is Primary?
You can use CHAMPVA and Medicare at the same time. When you use Medicare together with CHAMPVA, Medicare is the primary payer. CHAMPVA is a cost-sharing health coverage program for some military families who don't qualify for TRICARE. You can use CHAMPVA with Medicare when you're eligible for both programs. CHAMPA will be the secondary payer to Medicare and will pay most of your out-of-pocket costs. Since there are no additional premiums if you qualify for CHAMPVA, using it alongside Medicare can significantly lower your healthcare costs. Glossary of common Medicare terms Out-of-pocket cost: This is the amount you pay for care when Medicare doesn't pay the full cost or offer coverage. It includes premiums, deductibles, coinsurance, and copayments. Premium: This is the monthly amount you pay for Medicare coverage. Deductible: This is the annual amount you must spend out of pocket before Medicare begins to cover services and treatments. Coinsurance: This is the percentage of treatment costs you're responsible for paying out of pocket. With Medicare Part B, you typically pay 20%. Copayment: This is a fixed dollar amount you pay when receiving certain treatments or services. With Medicare, this often applies to prescription medications. What is CHAMPVA? The Civilian Health and Medical Program of the Department of Veterans Affairs (CHAMPVA) is a healthcare plan for certain dependents of veterans. CHAMPVA is a different program from TRICARE, which also services military members, veterans, and their families. TRICARE eligibility is open to people who are: active or retired uniformed service members spouses or children of active or retired uniformed service members members of the Army National Guard or Reserve spouses or children of Army National Guard or Reserve members spouses or children of deceased military members certain former spouses of military members Medal of Honor recipients spouses and children of Medal of Honor recipients You can't use CHAMPVA if you have or are eligible for TRICARE. CHAMPVA helps cover certain dependents who aren't eligible for TRICARE. For example, service members who leave active duty under certain conditions might not qualify for TRICARE. However, if they have a disability caused by their service, their family may be able to enroll in CHAMPVA. How does CHAMPVA work with Medicare? Since 2001, CHAMPVA beneficiaries have been able to use their coverage after turning 65 years old. This means CHAMPVA can be used alongside Medicare. You'll need to be enrolled in Medicare to keep your CHAMPVA coverage. Here are the rules for how that works: If you turned age 65 before June 5, 2001, and did not have Medicare Part B at the time, you only need to be enrolled in Medicare Part A to keep your CHAMPVA coverage. If you turned age 65 before June 5, 2001, and were already enrolled in Part B at that time, you need to be enrolled in both Part A and Part B to keep your CHAMPVA coverage. If you turned 65 years old after June 5, 2001, you need to be enrolled in parts A and B to keep your CHAMPVA coverage. Example For example, let's say you turned 65 years old in 1999 and enrolled in Medicare parts A and B. You won't be able to drop your Part B coverage and keep your CHAMPVA coverage. However, if you turned age 65 in 1999 and enrolled in only Part A, you wouldn't need to sign up for Part B to keep your CHAMPVA coverage. You can use CHAMPVA alongside: Original Medicare (parts A and B) Medicare Advantage (Part C) Medicare Part D, which is prescription drug coverage It's important to note that CHAMPVA won't pay for the cost of your Part B premium. You should also know that you can no longer use VA healthcare facilities or healthcare professionals once you're enrolled in Medicare. What services does CHAMPVA cover? CHAMPVA is a cost-sharing health insurance program. This means it will pay a portion of the cost of health services you receive, and you'll pay the remaining amount. You won't pay a premium for CHAMPVA, but there is a $50 deductible before coverage kicks in. After you pay your deductible, CHAMPVA will pay what's known as the 'allowable amount' for all covered services. Generally, CHAMPVA will pay 75% of the allowable amount, and you'll pay the other 25%. Covered services include: hospital stays primary care doctor visits specialist visits lab work skilled nursing care home care ambulance transportation mental health services prescription drugs There are two other completely covered benefits: Hospice care from any provider is 100% covered under CHAMPVA. You can also get prescription coverage at no cost to you if you use the Department of Veterans Affairs (VA) Meds by Mail program, if you have no other prescription drug coverage. Coverage works differently if you use CHAMPVA alongside another health insurance plan, including Medicare. When you use CHAMPVA with another insurance plan, CHAMPVA becomes what's called a secondary payer. This means your other insurance plan will be billed first, and CHAMPVA will then pay the remaining cost. This can save you a lot of money on out-of-pocket medical expenses like copayments or coinsurance amounts. Who pays first for healthcare costs? Medicare is the primary payer when you use it with CHAMPVA. This means Medicare will be the first to pay the cost of any service you receive, and then CHAMPVA will pay the rest. You'll have very few out-of-pocket costs using CHAMPVA and Medicare together since CHAMPVA will generally pay any copayments or coinsurance amounts. You can expect to pay: nothing out of pocket for any service that both Medicare and CHAMPVA cover your Medicare coinsurance cost of 20% for a service Medicare covers, but CHAMPVA doesn't your CHAMPVA cost sharing of 25% for anything CHAMPVA covers, but Medicare doesn't The same rules apply to Medicare Part D. CHAMPVA will pick up your copayments on all covered prescriptions. It will also pay 75% of the cost of prescriptions that your Medicare Part D plan doesn't cover. Present both your Medicare Part D plan card and your CHAMPVA ID card at your in-network pharmacy for coverage. Getting your coverage questions answered If you're not sure who will pay for a service, you can check ahead of time by: calling Medicare's Benefits Coordination & Recovery Center at 855-798-2627 (TTY: 855-797-2627) calling CHAMPVA customer care at 800-733-8387, Monday through Friday from 8:05 a.m. to 7:30 p.m. Eastern Standard Time What about Medicare Advantage? You can use your CHAMPVA coverage with a Medicare Advantage plan. Since Medicare Advantage plans replace Original Medicare, having an Advantage plan still meets the requirement to be enrolled in Medicare to keep CHAMPVA once you're age 65. Your Medicare Advantage plan will be the primary payer, just like when you have Original Medicare. CHAMPVA will pay your copayments and other out-of-pocket costs. Your bill will go to your Medicare Advantage plan first and then to CHAMPVA. In most cases, you won't have any out-of-pocket costs. Many Medicare Advantage plans also include Part D coverage. When you use a Medicare Advantage plan that includes Part D along with CHAMPVA, your CHAMPVA benefits will pick up the cost of your prescription copayments. Medicare Advantage plans often have networks. The network includes all the providers that your Medicare Advantage plan will cover healthcare services. In many cases, you'll need to pay out of pocket for any services you receive from an out-of-network provider. However, when you use CHAMPVA along with your Medicare Advantage plan, you can often get 75% of the cost of out-of-network services covered. How do I choose the right coverage options for me? You need to enroll in Original Medicare (parts A and B) to keep your CHAMPVA coverage. You can also choose to enroll in additional Medicare parts, such as: Medicare Advantage Medigap Medicare Part D The best option for you will depend on your personal needs and budget. Medicare Advantage, Medigap, and Medicare Part D plans have their own premiums, deductibles, and other costs. CHAMPVA can cover some of these costs, but not your premiums. You might not even need additional Medicare parts if you're using CHAMPVA. For example, Medigap plans are designed to cover the out-of-pocket costs of Medicare parts A and B. However, since CHAMPVA already does this when you use it alongside Medicare, you might not need a Medigap plan. Here are some other common scenarios to consider: Original Medicare + CHAMPVA Let's say you have CHAMPVA and Medicare parts A and B, and you choose not to enroll in any other Medicare plans. You'd pay the Medicare Part B premium, and Medicare would be your primary payer for all covered services. You could get prescriptions for 25% of the allowable amount at a pharmacy or completely covered if you use the Meds by Mail program using only CHAMPVA. Original Medicare + Part D + CHAMPVA You have CHAMPVA, Medicare parts A and B, and a Part D plan. You'd pay the Medicare Part B premium and the premium for your Part D plan. Medicare would be the primary payer for services and prescriptions. CHAMPVA would pick up your copayments and coinsurance amounts. Medicare Advantage + CHAMPVA You have CHAMPVA and a Medicare Advantage plan that includes Part D coverage. You'd pay the Medicare Part B premium plus the premium for your Medicare Advantage plan. Medicare would be the primary payer for your services and prescriptions. CHAMPVA would pay your copayments and coinsurance. Ways to save on Medicare coverage It's worth noting that you may be able to find Medicare Advantage or Medigap plans in your area with $0 premiums. You can shop for plans in your area on the Medicare website and compare prices, networks, and covered services before you commit to a plan. You can also look for savings on your Medicare coverage. You might qualify for programs to help lower your costs if you have a limited income. These programs include: Extra Help, which lowers your prescription drug costs Medicare savings programs, which can lower your costs for parts A and B Ultimately, the right plan for you depends on your needs and your budget. You'll want to select a plan that includes: the doctors you want to see any prescriptions you take any services you need You can also search for premiums in your price range, and those with out-of-pocket costs you can manage. How do I know if I'm eligible for CHAMPVA? You're eligible for CHAMPVA if you're the dependent child or the current or widowed spouse of a veteran who meets one of these conditions: is permanently and totally disabled from a service-related injury or disability was permanently and totally disabled from a service-related injury or disability at the time of their death died from service-related injury or disability died during active duty is not eligible for TRICARE There is no premium cost for CHAMPVA coverage. You can apply for CHAMPVA at any time. You'll need to send in an application along with documents that prove your eligibility. Depending on your circumstances, these might include: service records marriage records birth certificates You'll also need to send in information about any other insurance plan you currently have. Your application will generally be processed in 3 to 6 weeks. If your application is approved, you will receive a CHAMPVA card in the mail. As soon as your card arrives, you can start using CHAMPVA coverage. The takeaway When you use CHAMPVA with Medicare, CHAMPVA acts as the secondary payer. CHAMPVA doesn't cover Medicare premiums but will cover most of your other out-of-pocket healthcare expenses. CHAMPVA pays 75% of the cost of most services. The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
Yahoo
an hour ago
- Yahoo
Coal mines on Alberta's eastern slopes could push fishery 'beyond recovery': study
CALGARY — Old coal mines on the eastern slopes of the Alberta Rockies are leaching chemicals that are poisoning the fish downstream, says a new study by Alberta government scientists. It also suggests any new coal developments could result in "population collapse" of fish species in a nearby lake. The findings were made in a provincial government study posted online May 27. The paper is awaiting peer review. The scientists who authored it were not made available to speak to reporters. The other authors not employed by the province did not respond to requests for comment. Alberta has responded to the study with an advisory saying people should consider "limiting consumption" of three fish species drawn from Crowsnest Lake, a fishing spot downstream from the coal mines. Those species were found to have dangerously high levels of selenium, a mineral found in coal-rich deposits, in their body tissue. The authors write the study shows that "biological impacts of (mountaintop removal) coal mining can persist long after mining operations end." They suggest that "any further coal mine development may well push the Crowsnest fishery beyond sustainability.' The study comes after the Alberta Energy Regulator, or AER, granted an Australia-based coal company permission to start a controversial coal exploration on the eastern slopes. The project was initially rejected in 2021 when a panel ruled the likely environmental effects on fish and water quality outweighed potential economic benefits. But the regulator said last month it's possible there will be runoff from the nearby pit lake that Northback Holding Corp. is using. It ultimately concluded the project won't have any effect on the water quality downstream. The AER said that "out of an abundance of caution," Northback will have to comply with a directive for managing drilling waste in response to concerns over selenium. The new study measured selenium levels in fish from Crowsnest Lake, which is fed by creeks connected to Tent Mountain and Grassy Mountain – both former coal mine sites. Alberta has a fish tissue selenium guideline of four micrograms per gram. The authors write that every single fish sample analyzed exceeded this value. Average selenium concentrations were highest in Brown Trout, coming in at 18 micrograms per gram. The authors write that the selenium levels could lead to 'behavioural changes, physical symptoms ... respiratory issues, reproductive issues and ultimately population collapse." Accumulating fluid in body tissue or fin and tail damage are among other side effects. Most people are exposed to healthy levels of selenium through grains and flours, but Health Canada says elevated consumption can lead to hair loss, decreased cognitive function and gastrointestinal disorders. The high selenium concentrations can only be explained by "the incorporation of legacy coal mine pollution,' the authors write. The study goes on to say selenium levels in fish in Crowsnest Lake are similar to those found in water bodies near Fernie, B.C., that resulted in Teck Mining Company, which owned and operated a nearby mine, being forced in 2021 by B.C. provincial court to pay a $60 million fine – the largest fine ever imposed under the Fisheries Act. Fish populations in those mining-impacted streams were found in 2011 to have an average selenium concentration of 7.6 micrograms per gram. Nine years later, the adult westslope cutthroat population had suffered a 93 per cent decline, the study says. The authors conclude that factors including the emergence of Whirling Disease, drought conditions, high fishing activity -- and now high selenium levels in fish -- make the Crowsnest Lake and River "an especially vulnerable system.' 'Any new development of coal mining along the eastern slopes may well push the Crowsnest fishery beyond recovery,' they write. Colin Cooke, one of the authors, published a 2024 study that found a former coal mine in the Crowsnest River watershed was releasing selenium to fish at rates more than dozens of times higher than federal and provincial guidelines. Cooke is a senior aquatic scientist with the Alberta government, according to LinkedIn. Peter Doyle, CEO of Evolve Power Ltd., formerly Montem Resources Ltd., which previously sought to restart an old mine on Tent Mountain, said in an email that the company is complying with terms set out by the AER. "As reflected in other work by the author, there are numerous contributors to water quality in the Crowsnest River valley, not related to Tent Mountain, including changes in upstream conditions, changes in weathering rates and other anthropogenic changes in the watershed," Doyle wrote, referring to Cooke's 2024 study. That report notes those factors, among others, could be contributing to contaminant levels and concluded that coal mining activities in the Crowsnest River watershed "have been impacting ecosystems downstream for decades." Northback, in an email, wrote that Crowsnest Lake is unrelated to its Grassy Mountain project. "However, with our own project, Northback is committed to adhering to the highest environmental standards and ensuring a safe water supply." Ryan Fournier, press secretary for Alberta's environment ministry, deferred questions about monitoring and enforcement to the AER. He said the province is funding a series of studies and submitting them to peer-reviewed academic journals as the province revises its coal policy. He also said the authors were not available to speak to media because they "are not trained spokespeople." The AER told The Canadian Press that it has directed Evolve Power, the Tent Mountain owner, to submit a "selenium management plan proposal" that targets reductions in selenium in mine-affected water. Evolve was to submit that plan by July 31 of last year, but the AER said it granted the company an extension to March 31, 2026. The energy regulator also said that while selenium levels are elevated, "there is no evidence of non-compliance on monitoring or selenium management requirements at this time." The province announced in December it would allow coal mining to take place in Alberta under certain conditions. However, it exempted Northback and Evolve Power's projects from those rules because they were considered "advanced." Fisheries and Oceans Canada said in a statement that it doesn't comment on provincial permitting decisions and it hasn't been asked to review the local impacts to wildlife in the area. This report by The Canadian Press was first published June 6, 2025. Matthew Scace, The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data